DNAtriX Company

DNAtriX is a biotechnology company developing an oncolytic virus platform for treating malignant glioma.
Industry: Women Cancer Treatment
Headquarters: Houston, Texas, United States
Founded Date: 2005-01-01
Total Funding: $57 084 013
Estimated Revenue: $500M to $1B
Last Funding Date: 2018-09-12
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership